Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Speiser

Showing results (831-840 of 1,137) with videos related to

Pageof 114
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency)P W Speiser, N Laforgia, K Kato, et al.
Clinical & Developmental Immunology|December 28, 2013
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsFranz Buchegger, Steven M Larson, Jean-Pierre Mach, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2017
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV diseaseStefan Diem, Omar Hasan Ali, Christoph J Ackermann, et al.
The Analyst|May 22, 2013
Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embeddingM Verdonck, N Wald, J Janssis, et al.
Clinical and Experimental Immunology|October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapyM Montes, N Rufer, V Appay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseasesM J Pittet, A Zippelius, D E Speiser, et al.
Bone Marrow Transplantation|November 1, 1995
Histoincompatibilities in ABDR-matched unrelated donor recipient combinationsN Rufer, J M Tiercy, B Breur-Vriesendorp, et al.
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patientsGeorg Alexander Rockinger, Philippe Guillaume, Amélie Cachot, et al.
Pageof 114

Showing results (831-840 of 1,137) with videos related to

Sort By:
Pageof 114
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency)P W Speiser, N Laforgia, K Kato, et al.
Clinical & Developmental Immunology|December 28, 2013
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsFranz Buchegger, Steven M Larson, Jean-Pierre Mach, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2017
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV diseaseStefan Diem, Omar Hasan Ali, Christoph J Ackermann, et al.
The Analyst|May 22, 2013
Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embeddingM Verdonck, N Wald, J Janssis, et al.
Clinical and Experimental Immunology|October 20, 2005
Optimum in vitro expansion of human antigen-specific CD8 T cells for adoptive transfer therapyM Montes, N Rufer, V Appay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseasesM J Pittet, A Zippelius, D E Speiser, et al.
Bone Marrow Transplantation|November 1, 1995
Histoincompatibilities in ABDR-matched unrelated donor recipient combinationsN Rufer, J M Tiercy, B Breur-Vriesendorp, et al.
Gynecologic Oncology|September 29, 2012
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortiumEva Obermayr, Dan Cacsire Castillo-Tong, Dietmar Pils, et al.
Journal for Immunotherapy of Cancer|May 26, 2020
Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patientsGeorg Alexander Rockinger, Philippe Guillaume, Amélie Cachot, et al.
Pageof 114